Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line Helicobacter pylori eradication: a double-blind randomized controlled trial

FONDECYT (1230504 AR); ANID-FONDAP (152220002 AR); Horizon 2020 program of European Union (825832 AR); ANID-FONDAP (15130011).

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Americas
Published
2025-11-22
DOI
https://doi.org/10.1016/j.lana.2025.101312
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line Helicobacter pylori eradication: a double-blind randomized controlled trial

Patricio Medel‐Jara, Arnoldo Riquelme Pérez, Ignacio Wichmann, Shailja C. Shah et al.
The Lancet Regional Health - Americas
Helicobacter pylori-related gastroenterology studies
article

Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line Helicobacter pylori eradication: a double-blind randomized controlled trial

Patricio Medel‐Jara, Arnoldo Riquelme Pérez, Ignacio Wichmann, Shailja C. Shah, José Ignacio Vargas, Javier Chahuán, Óscar Corsi, Nelson Varela, Luis A. Quiñones, Robert J. Huang, Margarita Pizarro, Carolina Serrano, Leslie C. Cerpa, Françis Mégraud, Eduardo Fuentes–López, Alberto Espino, Sara Maquilón, Paola Viviani, Paul R. Harris, Christopher Sandoval, Diego Reyes, Gonzalo Latorre, Isabella Buruato
article en

Abstract

FONDECYT (1230504 AR); ANID-FONDAP (152220002 AR); Horizon 2020 program of European Union (825832 AR); ANID-FONDAP (15130011).

The Lancet Regional Health - AmericasVol. 53
Université de Bordeaux (FR), Inserm (FR), Pontificia Universidad Católica de Chile (CL), VA San Diego Healthcare System (US), Bordeaux Population Health (FR), Advanced Center for Chronic Diseases (CL), PharmacoGenetics (China) (CN), BoRdeaux Institute of onCology (FR), University of Chile (CL), Stanford University (US)
European Commission, Agencia Nacional de Investigación y Desarrollo, Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias
Openalex Percentile: Top 41%
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.